[Therapy of metastatic mammary carcinoma with cyclophosphamide, methotrex ate, vincristine and fluorouracil ].
D000728:Androgens / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004357:Drug Synergism; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008408:Mastectomy; D008727:Methotrexate / Q000627:therapeutic use*; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use*
D000728:Androgens; D004967:Estrogens; D011372:Progestins; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Terapia del carcinoma mammario metastatizzato con ciclofosfamide, methotrexate, vincristina e fluorouracile.